Trails Edge Capital Partners, LP: DESIGN THERAPEUTICS INC (DSGN): Quarterly 13F Position History
As of Q2 2026, Trails Edge Capital Partners, LP reported 2,001,282 shares of DESIGN THERAPEUTICS INC (DSGN), worth $29.0M and representing 4.6% of its 13F equity book. Quarter-over-quarter share count change: + 1,149,269 (+134.9%) . The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 2,001,282Shares Held (Latest Filing)
- $29.0MReported Market Value (Latest Filing)
- 4.6%Portfolio Weight (% of 13F Equity Book)
- +1,149,269Quarter-over-Quarter Share Change
- +$19.9MQuarter-over-Quarter Value Change
- 2,001,282Peak Reported Shares (Historical)
Recent initiation: Trails Edge Capital Partners, LP first reported DSGN on the Q1 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,001,282 | +1,149,269 | +134.9% | $29.0M | 4.6% | $14.5 |
| Q1 2026 | 852,013 | – | – | $9.1M | 2.1% | $10.6 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Trails Edge Capital Partners, LP first disclose a DSGN position in 13F-HR filings?
Trails Edge Capital Partners, LP first reported DESIGN THERAPEUTICS INC (DSGN) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Trails Edge Capital Partners, LP's most recent quarter-over-quarter share-count change in DSGN?
Between Q1 2026 and Q2 2026, Trails Edge Capital Partners, LP added 1,149,269 shares of DSGN (+134.9%), bringing the total reported position to 2,001,282 shares at a market value of $29.0M.
Does the implied price-per-share represent Trails Edge Capital Partners, LP's cost basis in DSGN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.